Suchergebnisse

Energy issues and energy poverty became very important when dealing with global development challenges and sustainable development agenda, and as the years pass more precise indicators are formed to follow this phenomenon from various perspectives. One way to follow and analyze energy poverty is through the indicators proposed by the European Commission and the Survey on Income and Living Conditions (EU-SILC). Based on the main EU-SILC indicators for Serbia for 2020, this analysis explored a relationship between energy poverty and household income disaggregated by available data about regions, degree of urbanization, household types, and sex-age structure. It also tended to position Serbia within the European context regarding energy poverty. Based on the available data, it was found that people living in thinly populated areas expressed a higher share of vulnerabilities than those living in densely populated areas. Also, persons at risk of poverty are more vulnerable than the total population. When it comes to household types, people living in a single-person household are the most vulnerable, followed by the single-parent household with dependent children.

This paper explores the hypothesis that there is a connection between the standard of living (expressed by the Human Development Index) and the standardised rates of breast cancer incidence and mortality in the female population of Europe. The examination whether the standard of living has an impact on breast cancer incidence and mortality is based on the use of bivariate correlation, as the simplest form of quantitative analysis of two variables which seeks to determine the empirical relationship between them. The second part of the analysis involves the determination of linear relationships using simple linear regression analysis models testing the average impact of the Human Development Index on the standardised breast cancer incidence and mortality rates. The analysis takes into account the importance of yet another socioeconomic factor – response to screening, which can have a major impact on breast cancer mortality.